Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC ...

Novavax Inc. had an impressive 2024, with its stock gaining nearly 68%. The momentum has continued into 2025, with shares up ...

Novavax shares are trading higher by 12.4% during Tuesday's session. A recent CDC report highlights a sharp increase in ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

The stock's fall snapped a five-day winning streak.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $10.82 which represents a slight increase of $1.06 or 10.86% from the prior close of $9.76. The stock opened at $9.95 and touched a low ...

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

Shares of Moderna, Inc. and Novavax, Inc. jumped premarket Tuesday, rising as much as about 6% and nearly 8%, respectively, ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.